Novo Nordisk cuts forecasts amid U.S. drug rivalry, but reports strong Q1 results and responds with expanded access and price cuts.
Newly confirmed Social Security Commissioner Frank Bisignano faces scrutiny over agency's restructuring amid concerns about service disruptions and job cuts.
Novo Nordisk cuts forecasts amid U.S. drug rivalry, but reports strong Q1 results and responds with expanded access and price cuts.
Newly confirmed Social Security Commissioner Frank Bisignano faces scrutiny over agency's restructuring amid concerns about service disruptions and job cuts.